Background This background document was prepared by the Strategic Advisory Group of
Experts (SAGE) on Immunization Working Group on COVID-19 Vaccines to inform the …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

One of the major breakthroughs to combat the current Coronavirus Disease 2019 (COVID-
19) pandemic has been the development of highly effective vaccines against the Severe …

Summary mRNA-1273 vaccine efficacy against SARS-CoV-2 Delta wanes over time;
however, there are limited data on the impact of durability of immune responses on …

Serological tests detect antibodies generated by infection or vaccination, and are
indispensable tools along different phases of a pandemic, from early monitoring of pathogen …

Background Neutralizing mAbs can prevent communicable viral diseases. MK-1654 is a
respiratory syncytial virus (RSV) F glycoprotein neutralizing monoclonal antibody (mAb) …

IgG antibodies are important mediators of vaccine-induced immunity through complement-
and Fc receptor-dependent effector functions. Both are influenced by the composition of the …

Despite the rapid creation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) vaccines, the precise correlates of immunity against severe Coronavirus Disease …

Background Vaccines remain the cornerstone for containing the SARS-CoV-2 pandemic.
mRNA vaccines provide protection in clinical trials using a two-dose approach, separated by …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of
2019 and is responsible for the largest human pandemic in 100 years. Thirty-four vaccines …